(Q47567375)
Statements
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057) (English)
Everett E Vokes
Hossein Borghaei
David R Spigel
Neal Ready
Esther Holgado
Fabrice Barlesi
Jérôme Fayette
Naiyer Rizvi
Lucio Crinò
Scott Antonia
Julie Brahmer
Martin Reck
Leora Horn
Martin Steins
Luis Paz-Ares
Karen L Reckamp
Marco A Burgio
Martin Kohlhäeufl
David Waterhouse
Matthew D Hellmann
William J Geese
Ang Li
Anne Blackwood-Chirchir
Diane Healey
Wilfried E E Eberhardt
12 October 2017